DelSiTech is excited to participate in two of Europe’s premier life sciences events this spring: BIO-Europe Spring and LSX World Congress Europe. These back-to-back conferences will take place in Lisbon, Portugal, from 23–26 March 2026, forming the inaugural Life Sciences Spring Innovation Week.
-
- BIO-Europe Spring (23–25 March) – Europe’s largest springtime biotech partnering event, connecting global pharma, biotech innovators, and licensing professionals.
- LSX World Congress Europe (25–26 March, with pre-day forums on 24 March) – A leading platform for life sciences investment, fundraising, and strategic partnering, focused on early- to growth-stage companies and investors.
This unique co-location brings together the full innovation ecosystem: from early-stage biotechs and academic spinouts to leading pharmaceutical companies, venture capital firms, and strategic partners.
Our Chief Commercial Officer Frederic Dargelas and Business Development & Alliance Manager Milla Runsala will be on-site throughout the week and available for one-on-one meetings. We warmly invite discussions on:
-
- New strategic partnerships to advance therapeutic development pipelines
- Opportunities to explore our proprietary Silica Matrix drug delivery platform – a biodegradable, ultra-long-acting silica-based technology ideal for small molecules, peptides, and biologics
- Investment interest in our ongoing programs in pain management and obesity
If you are attending Spring Innovation Week in Lisbon and would like to schedule a meeting with our team or learn more about DelSiTech’s innovative drug delivery solutions, please contact Frederic or Milla directly on LinkedIn. You can also reach us through the partnering portal or the contact form.
We look forward to connecting in Lisbon and exploring how we can collaborate to drive the next generation of therapeutics.